Navigating the replacement of a leadless pacemaker after years can be a daunting journey filled with intricate decisions. While opting to retain the old device might appear to be the safer route, ...

VIENNA, Austria—Patients who require a pacemaker implant in the 30 days after TAVI have significantly greater risks of death up to a decade later, according to an analysis of the Swiss TAVI registry.

The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the company’s implanted Accolade pacemakers, which may need to be replaced earlier ...

MD+DI Senior Editor Amanda Pedersen explores the urgent need for transparency in medical device reporting, highlighting ...

The prospective multi-centre BIO-LivIQ trial will enrol 325 patients across 60 sites worldwide.

Background: Patients over the age of 75 represent more than half the recipients of permanent pacemakers. It is not known if they have a different risk of complications than younger patients. Methods: ...

Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found ...

The problem with the Accolade pacemaker had to do with its battery life. Thomas’ March 19 New York Times story revealed that, “for years, factory tests had revealed pacemaker batteries that were ...